Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-25 @ 9:15 PM
Study NCT ID:
NCT04494256
Status:
TERMINATED
Last Update Posted:
2025-10-09
First Post:
2020-07-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-13
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-30
First Submit QC Date:
None
Study First Post Date:
2020-07-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-08-12
Results First Submit QC Date:
None
Results First Post Date:
2025-10-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-23
Last Update Post Date:
2025-10-09
Last Update Post Date Type:
ESTIMATED